Back to top
Top
U.S. flag

An official website of the United States government

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

All eCQMs associated with: Process

Year Type CMS eCQM ID Measure Name
2024 EC CMS153v12 Chlamydia Screening in Women
2023 EC CMS153v11 Chlamydia Screening in Women
2022 EC CMS153v10 Chlamydia Screening for Women
2025 EC CMS149v13 Dementia: Cognitive Assessment
2024 EC CMS149v12 Dementia: Cognitive Assessment
2023 EC CMS149v11 Dementia: Cognitive Assessment
2022 EC CMS149v10 Dementia: Cognitive Assessment
2023 EC CMS147v12 Preventive Care and Screening: Influenza Immunization
2022 EC CMS147v11 Preventive Care and Screening: Influenza Immunization
2025 EC CMS146v13 Appropriate Testing for Pharyngitis
2024 EC CMS146v12 Appropriate Testing for Pharyngitis
2023 EC CMS146v11 Appropriate Testing for Pharyngitis
2022 EC CMS146v10 Appropriate Testing for Pharyngitis
2025 EC CMS145v13 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
2024 EC CMS145v12 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF) less than or equal to 40%
2023 EC CMS145v11 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than or equal to 40%)
2022 EC CMS145v10 Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF less than 40%)
2025 EC CMS144v13 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2024 EC CMS144v12 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2023 EC CMS144v11 Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)